1. Home
  2. CINT vs AQST Comparison

CINT vs AQST Comparison

Compare CINT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CINT

CI&T Inc

HOLD

Current Price

$3.01

Market Cap

458.2M

Sector

Technology

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.92

Market Cap

529.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CINT
AQST
Founded
1995
2004
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
458.2M
529.4M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
CINT
AQST
Price
$3.01
$4.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$7.35
$9.00
AVG Volume (30 Days)
89.3K
2.4M
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$67,430,000.00
Revenue This Year
$16.69
$10.08
Revenue Next Year
$11.28
$49.60
P/E Ratio
$17.94
N/A
Revenue Growth
N/A
0.77
52 Week Low
$2.80
$2.94
52 Week High
$6.06
$7.55

Technical Indicators

Market Signals
Indicator
CINT
AQST
Relative Strength Index (RSI) 41.08 54.82
Support Level $2.80 $4.03
Resistance Level $3.62 $5.10
Average True Range (ATR) 0.18 0.24
MACD -0.02 -0.07
Stochastic Oscillator 34.71 45.13

Price Performance

Historical Comparison
CINT
AQST

About CINT CI&T Inc

CI&T Inc operates as a partner in tech-integrated business solutions, helping organizations address complex challenges by integrating business approach, technology, and artificial intelligence into a single, coherent operating model. It is mainly engaged in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, data analytics, cloud migration and mobility technologies. The company provides technology services to various industry verticals, including Financial Services, Consumer Goods, Technology and Communications, Retail and Industrial Goods, Life Sciences, among others. The majority of the revenue is derived from providing technology services. Geographically, maximum revenue is derived from Brazil.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: